Indefinite Delivery Contract 36C24822D0048

Award Date 3/16/22
Last Date to Order 3/14/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The U.S. Department of Veterans Affairs (VA) awarded Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, an Indefinite Delivery Contract (IDC) valued at up to $39.8 million to provide radiopharmaceuticals to VA medical facilities. Jubilant Radiopharma, a for-profit organization and self-certified small disadvantaged business, will supply diagnostic imaging agents, therapeutic radiopharmaceuticals, and nuclear medicine supplies, including products such as Ga-68...
The U.S. Department of Veterans Affairs (VA) has awarded an Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business, for the supply of nuclear medicine radiopharmaceuticals. The IDC, with a ceiling value of $1,500,000, has a performance period of April 27, 2023 to April 26, 2028. Under this IDC, the VA has issued several firm-fixed-price delivery orders to Jubilant Radiopharma for the...
The Department of Veterans Affairs (VA) has awarded a single-award Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business, for the provision of radiopharmaceuticals. The IDC, valued at up to $2.6 million, has an ultimate completion date of March 4, 2029 and is not set-aside. As a subsidiary of Jubilant Life Sciences Limited, Jubilant Radiopharma specializes in manufacturing,...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded an Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, for the procurement of nuclear medicine radiopharmaceuticals. The single-award IDC has a total contract ceiling of $220,000 and a performance period running through March 31, 2030. Jubilant Radiopharma, a for-profit small disadvantaged business, will provide a range of specialized...
The Department of Veterans Affairs (VA) has awarded an Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business. The $2.29 million single-award IDC, with a period of performance through January 2030, is for the supply of radiopharmaceuticals, including specialized medical isotopes, diagnostic imaging agents, and therapeutic radioisotopes, to support nuclear medicine procedures, PET scans,...
The U.S. Department of Veterans Affairs (VA) Veterans Health Administration awarded an Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a for-profit organization, to provide radiopharmaceuticals and related products and services to support diagnostic imaging and treatment procedures at VA medical facilities. The IDC has a potential value of $3,000,000 and runs through September 30, 2028. Jubilant Radiopharma, which is...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) has awarded Jubilant Draximage Inc., doing business as Jubilant Radiopharma, Division Radiopharmaceutique, an Indefinite Delivery Contract (IDC) valued up to $3.5 million for the provision of radioactive isotopes and related radiopharmaceutical products and services. This single-award IDC with the VA VISN 10 network has a period of performance through September 30, 2026. Under this IDC, Jubilant Radiopharma, a...
The federal contract IDV awarded by the Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business, is for the supply of radiopharmaceuticals. The $740,177.94 firm-fixed-price delivery order contract is part of a larger $39.8 million multiple-award Indefinite Delivery Contract (IDC) with the VA's Network Contracting Office 8, as well as additional IDVs with the VA and Defense Health...
This indefinite delivery contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business. The $950,000 single-award IDC covers the provision of nuclear radiopharmaceuticals to support medical operations for the VA's Veterans Integrated Service Network (VISN) 21. Under this IDC, Jubilant Radiopharma has received multiple firm fixed-price delivery orders to...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded a single-award, indefinite delivery contract to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, with a potential value of $420,000. The contract establishes Jubilant Radiopharma as the supplier of nuclear medicine radiopharmaceuticals to support VA healthcare programs in the Norcross, Georgia area over a five-year period of performance from December...
  • 36C24822D0048
    Indefinite Delivery Contract
  • 4
    Federal Contract Awards

The Department of Veterans Affairs (VA) has awarded a single-award Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business, to supply radiopharmaceutical products such as gallium-68 dotatate. Valued at a ceiling of $1.5 million, this IDC has a period of performance through March 2026 and was awarded to Jubilant Radiopharma under unrestricted competition, with no set-aside designation.

Under this IDC, the VA has issued several firm-fixed-price delivery orders to Jubilant Radiopharma, totaling over $1.9 million, for the supply of critical radiopharmaceuticals used in nuclear medicine procedures at VA medical facilities in Florida, Georgia, and other regions. The radiopharmaceuticals, such as gallium-68 dotatate for PET imaging, support diagnostic imaging and treatment services for veterans. Jubilant Radiopharma, with expertise in manufacturing and distributing radiopharmaceuticals, has accumulated over $10 million in federal contract funding through its IDCs and Blanket Purchase Agreements with the VA and Department of Defense to date, enabling efficient nationwide procurement of these specialized medical isotopes and tracers.

Generated 2/19/25, 9:07 AM